OBJECTIVE: We sought to estimate what proportion of adults plan to stop cancer screening tests among adults who recently considered screening and to explore factors associated with these screening plans. DESIGN: Telephone Survey PARTICIPANTS: A total of 1,237 participants aged 50 and older who reported having made one or more cancer screening decisions in the past 2 years completed 1,454 cancer screening modules for breast, prostate and colorectal screening. MAIN RESULTS: Of all module respondents, 9.8% reported plans to stop screening, 12.6% for breast, 6.0 % for prostate and 9.5% for colon cancer. We found no statistically significant differences in plans to stop for those ages >or=70 (8.2%) compared to those ages 50 to 69 (10.2%) (p = 0.14.) Black respondents were less likely to report plans to stop than white respondents (OR = 0.32, 95% CI 0.12, 0.87). Participation in the decision-making process was associated with plans to stop screening; those who reported they made the final decision about screening (OR 5.9, 95% CI 1.4, 24.7) or made the decision with the health care provider (OR 4.1, 95% CI 1.0, 16.8) were more likely to have plans to stop screening compared to respondents who reported that their health care provider made the final decision. CONCLUSIONS: Plans to stop screening were uncommon among participants who had recently faced a screening decision. Given the recent US Preventive Services Task Force recommendations limiting routine cancer screening for older adults, additional efforts to educate adults about the potential risks and benefits of screening may be warranted.
OBJECTIVE: We sought to estimate what proportion of adults plan to stop cancer screening tests among adults who recently considered screening and to explore factors associated with these screening plans. DESIGN: Telephone Survey PARTICIPANTS: A total of 1,237 participants aged 50 and older who reported having made one or more cancer screening decisions in the past 2 years completed 1,454 cancer screening modules for breast, prostate and colorectal screening. MAIN RESULTS: Of all module respondents, 9.8% reported plans to stop screening, 12.6% for breast, 6.0 % for prostate and 9.5% for colon cancer. We found no statistically significant differences in plans to stop for those ages >or=70 (8.2%) compared to those ages 50 to 69 (10.2%) (p = 0.14.) Black respondents were less likely to report plans to stop than white respondents (OR = 0.32, 95% CI 0.12, 0.87). Participation in the decision-making process was associated with plans to stop screening; those who reported they made the final decision about screening (OR 5.9, 95% CI 1.4, 24.7) or made the decision with the health care provider (OR 4.1, 95% CI 1.0, 16.8) were more likely to have plans to stop screening compared to respondents who reported that their health care provider made the final decision. CONCLUSIONS: Plans to stop screening were uncommon among participants who had recently faced a screening decision. Given the recent US Preventive Services Task Force recommendations limiting routine cancer screening for older adults, additional efforts to educate adults about the potential risks and benefits of screening may be warranted.
Authors: Brian J Zikmund-Fisher; Mick P Couper; Eleanor Singer; Carrie A Levin; Floyd J Fowler; Sonja Ziniel; Peter A Ubel; Angela Fagerlin Journal: Med Decis Making Date: 2010-04-14 Impact factor: 2.583
Authors: Evelyn C Y Chan; Sally W Vernon; Frederick T O'Donnell; Chul Ahn; Anthony Greisinger; Donnie W Aga Journal: Am J Public Health Date: 2003-05 Impact factor: 9.308
Authors: Carmen L Lewis; Christine E Kistler; Halle R Amick; Lea C Watson; Debra L Bynum; Louise C Walter; Michael P Pignone Journal: BMC Geriatr Date: 2006-08-03 Impact factor: 3.921
Authors: Jennifer L Moss; Siddhartha Roy; Chan Shen; Joie D Cooper; Robert P Lennon; Eugene J Lengerich; Alan Adelman; William Curry; Mack T Ruffin Journal: JAMA Netw Open Date: 2020-07-01
Authors: Ashley J Housten; Monique R Pappadis; Shilpa Krishnan; Susan C Weller; Sharon H Giordano; Therese B Bevers; Robert J Volk; Diana S Hoover Journal: Psychooncology Date: 2018-04-17 Impact factor: 3.894
Authors: Nancy L Schoenborn; Kimberley Lee; Craig E Pollack; Karen Armacost; Sydney M Dy; John F P Bridges; Qian-Li Xue; Antonio C Wolff; Cynthia Boyd Journal: JAMA Intern Med Date: 2017-08-01 Impact factor: 21.873
Authors: David H Howard; Florence K Tangka; Gery P Guy; Donatus U Ekwueme; Joseph Lipscomb Journal: Health Aff (Millwood) Date: 2013-03 Impact factor: 6.301